LETROZOLEXIN 2.5 - Euro-Pharmacies

Letrozole, a selective third-generation aromatase inhibitor, effectively lowers estrogen, making it ideal for breast cancer treatment in postmenopausal women. Often sold under the brand Femara, it is recognized globally for its ability to reduce estrogen by up to 78%. Its mechanism prevents conversion of testosterone to estrogen, which can support athletes seeking estrogen reduction during cycles. However, prolonged use may impact cholesterol levels and reduce HDL, increasing cardiovascular risks. This feature, while powerful, means many athletes opt for cyclic use rather than prolonged dosage​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about LETROZOLEXIN 2.5 by Euro-Pharmacies, consult with your doctor or healthcare professional.